Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Nature Medicine volume 10, pages 182–186 (2004)Cite this article

Abstract

Metastatic cancers, once established, are the primary cause of mortality associated with cancer. Previously, we used a genomic approach to identify metastasis-associated genes in cancer1. From this genomic data, we selected ezrin for further study based on its role in physically and functionally connecting the actin cytoskeleton to the cell membrane2. In a mouse model of osteosarcoma, a highly metastatic pediatric cancer, we found ezrin to be necessary for metastasis. By imaging metastatic cells in the lungs of mice, we showed that ezrin expression provided an early survival advantage for cancer cells that reached the lung. AKT and MAPK phosphorylation and activity were reduced when ezrin protein was suppressed. Ezrin-mediated early metastatic survival was partially dependent on activation of MAPK, but not AKT. To define the relevance of ezrin in the biology of metastasis, beyond the founding mouse model, we examined ezrin expression in dogs that naturally developed osteosarcoma. High ezrin expression in dog tumors was associated with early development of metastases. Consistent with this data, we found a significant association between high ezrin expression and poor outcome in pediatric osteosarcoma patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Suppression of ezrin protein and disruption of ezrin function significantly reduced lung metastases in mice.
Figure 2: Suppression of ezrin protein resulted in decreased signaling and activity of AKT and p44/42 MAPK pathways in highly metastatic K7M2 osteosarcoma cells.
Figure 3: High primary tumor expression of ezrin was associated with significantly shortened DFI in pet dogs and pediatric patients with osteosarcoma.

Similar content being viewed by others

References

  1. Khanna, C. et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 61, 3750–3759 (2001).

    CAS  PubMed  Google Scholar 

  2. Algrain, M., Turunen, O., Vaheri, A., Louvard, D. & Arpin, M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J. Cell Biol. 120, 129–139 (1993).

    Article  CAS  Google Scholar 

  3. Bretscher, A., Edwards, K. & Fehon, R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3, 586–599 (2002).

    Article  CAS  Google Scholar 

  4. Nguyen, R., Reczek, D. & Bretscher, A. Hierarchy of merlin and ezrin N and C-terminal domain interactions in homo and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J. Biol. Chem. 276, 7621–7629 (2001).

    Article  CAS  Google Scholar 

  5. Martin, T.A., Harrison, G., Mansel, R.E. & Jiang, W.G. The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol. 46, 165–186 (2003).

    Article  Google Scholar 

  6. Ohtani, K. et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett. 179, 79–86 (2002).

    Article  CAS  Google Scholar 

  7. Makitie, T., Carpen, O., Vaheri, A. & Kivela, T. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest. Ophthalmol. Vis. Sci. 42, 2442–2449 (2001).

    CAS  PubMed  Google Scholar 

  8. Gautreau, A., Louvard, D. & Arpin, M. Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J. Cell Biol. 150, 193–203 (2000).

    Article  CAS  Google Scholar 

  9. Chambers, A.F. et al. Critical steps in hematogenous metastasis: an overview. Surg. Oncol. Clin. N. Am. 10, 243–255 (2001).

    Article  CAS  Google Scholar 

  10. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000).

    Article  CAS  Google Scholar 

  11. Chambers, A.F., Naumov, G.N., Vantyghem, S.A. & Tuck, A.B. Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res. 2, 400–407 (2000).

    Article  CAS  Google Scholar 

  12. Wong, C.W. et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am. J. Pathol. 161, 749–753 (2002).

    Article  Google Scholar 

  13. Wong, C.W. et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333–338 (2001).

    CAS  Google Scholar 

  14. Luzzi, K.J. et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865–873 (1998).

    Article  CAS  Google Scholar 

  15. Gautreau, A., Poullet, P., Louvard, D. & Arpin, M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3–kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 96, 7300–7305 (1999).

    Article  CAS  Google Scholar 

  16. Ward, Y. et al. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol. Cell Biol. 21, 5958–5969 (2001).

    Article  CAS  Google Scholar 

  17. Vail, D.M. & MacEwen, E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18, 781–792 (2000).

    Article  CAS  Google Scholar 

  18. Withrow, S.J., Powers, B.E., Straw, R.C. & Wilkins, R.M. Comparative aspects of osteosarcoma. Dog versus man. Clin. Orthop. 270, 159–168 (1991).

    Google Scholar 

  19. Khanna, C. et al. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy. Clin. Cancer Res. 8, 2406–2412 (2002).

    CAS  PubMed  Google Scholar 

  20. Crepaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D. & Arpin, M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138, 423–434 (1997).

    Article  CAS  Google Scholar 

  21. Hiscox, S. & Jiang, W.G. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/β-catenin. J. Cell Sci. 112, 3081–3090 (1999).

    CAS  PubMed  Google Scholar 

  22. Yu, Y. et al. Expression profiling identifies the cytoskeletal organizer Ezrin and the developmental homeoprotein Six1 as key metastatic regulators. Nat. Med. 10, 48–54 (2004)

    Article  Google Scholar 

  23. Reddy, K.B., Nabha, S.M. & Atanaskova, N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 4, 395–403 (2003).

    Article  Google Scholar 

  24. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54 (2003).

    Article  CAS  Google Scholar 

  25. Khanna, C. et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18, 261–271 (2000).26.

    Article  CAS  Google Scholar 

  26. Lamb, R. et al. Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr. Biol. 7, 682–688 (1997).

    Article  CAS  Google Scholar 

  27. Wan, X. & Helman, L.J. Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway. Neoplasia 4, 400–408 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank P. Meltzer and J. Khan for useful discussions; B. Spinelli and K. Kelly for assistance with ezrin-T567A mutagenesis; the Pediatric Cooperative Human Tissue Network and Children's Oncology Group for contributions of tissue; and M. Devidas for collection of patient outcome data.

Author information

Authors and Affiliations

  1. Pediatric Oncology Branch and Tissue Array Project Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Chand Khanna, Xiaolin Wan, Seuli Bose, Ryan Cassaday, Osarenoma Olomu, Arnulfo Mendoza, Choh Yeung & Lee J Helman

  2. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Stephen M Hewitt

  3. Memorial Sloan Kettering Cancer Center, New York, 10021, New York, USA

    Richard Gorlick

Authors
  1. Chand Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaolin Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seuli Bose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryan Cassaday
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Osarenoma Olomu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Arnulfo Mendoza
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Choh Yeung
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Richard Gorlick
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stephen M Hewitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Lee J Helman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chand Khanna.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khanna, C., Wan, X., Bose, S. et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10, 182–186 (2004). https://doi.org/10.1038/nm982

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm982

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing